An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials.

Trial Profile

An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Oct 2012

At a glance

  • Drugs Insulin (Primary)
  • Indications Diabetes mellitus
  • Focus Adverse reactions
  • Acronyms FUSE
  • Sponsors Pfizer
  • Most Recent Events

    • 26 Jun 2012 Actual patient number changed from 2725 to 7439 as reported by ClinicalTrials.gov.
    • 27 Mar 2012 Actual end date (January 2012) added as reported by ClinicalTrials.gov.
    • 27 Mar 2012 Actual patient number (2725) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top